Results 351 to 360 of about 3,327,333 (431)

Development and comparison of single FLT3-inhibitors to dual FLT3/TAF1-inhibitors as an anti-leukemic approach. [PDF]

PLoS One
Leigh RS, Kaynak BL, Ruskoaho H, Välimäki MJ.   +3 more
europepmc   +1 more source

Characterization of temperature-sensitive alleles of anillin-like Mid1 and polo kinase Plo1 in <i>Schizosaccharomyces pombe</i>. [PDF]

MicroPubl Biol
Park JS, Turner LA, Gould KL, Willet AH.
europepmc   +1 more source

Inferring kinase-phosphosite regulation from phosphoproteome-enriched cancer multi-omics datasets. [PDF]

Brief Bioinform
Cheng H, Liang Z, Wu Y, Hu J, Cao B, Liu Z, Liu B, Cheng H, Liu ZX.   +8 more
europepmc   +1 more source

Dapagliflozin in Chronic Kidney Disease: Insights from Network Pharmacology and Molecular Docking Simulation. [PDF]

Life (Basel)
Phongphithakchai A, Tedasen A, Netphakdee R, Leelawattana R, Srithongkul T, Raksasuk S, Huang JC, Chatatikun M.   +7 more
europepmc   +1 more source

Metabolic Reprogramming in Stromal and Immune Cells in Rheumatoid Arthritis and Osteoarthritis: Therapeutic Possibilities. [PDF]

Eur J Immunol
Henry ÓC, O'Neill LAJ.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Trends in kinase drug discovery: targets, indications and inhibitor design

Nature Reviews Drug Discovery, 2021
Helgi B Schiöth, Misty M Attwood, Stefan Knapp   +2 more
exaly   +2 more sources

Oncogenic kinase signalling

Nature, 2001
Tony Hunter
exaly   +2 more sources